In colorectal cancer cell lines with different p53 status, BA reduced p53 protein level in a dose-dependent manner, while in oral squamous cell carcinoma, p53 protein level was enhanced [11,40]. The gene discussed is TP53; the disease is oral cavity squamous cell carcinoma.